Table 4.
Clinical Outcomes
| Type 1 MI | |||||||
|---|---|---|---|---|---|---|---|
|
|
|||||||
| All Type 1 MI (n=137) |
NSTEMI (n=117) |
STEMI (n=20) |
Type 2 MI (n=146) |
Myocardial Injury (n=175) |
P1† | P2* | |
| In-Hospital Mortality | 18 (13.1) | 13 (11.1) | 5 (25.0) | 17 (11.6) | 16 (9.1) | 0.70 | 0.46 |
| Cardiovascular Death | 8 (44.4) | 4 (30.8) | 4 (80.0) | 3 (17.6) | 4 (25.0) | 0.18 | 0.69 |
| Non-cardiovascular Death | 10 (55.6) | 9 (69.2) | 1 (20.0) | 14 (82.4) | 12 (75.0) | - | - |
| In-hospital or 30-Day Mortality | 21 (15.3) | 15 (12.8) | 6 (30.0) | 22 (15.1) | 23 (13.1) | 0.92 | 0.62 |
| Cardiovascular Death | 9 (42.9) | 4 (26.7) | 5 (83.3) | 6 (27.3) | 7 (30.4) | 0.45 | 0.92 |
| Non-cardiovascular Death | 11 (52.4) | 10 (66.7) | 1 (16.7) | 15 (68.2) | 15 (65.2) | - | - |
| Unknown Cause of Death | 1 (4.8) | 1 (6.7) | 0 (0.0) | 1 (4.5) | 1 (4.3) | - | - |
| All-Cause Mortality on intermediate-term follow-up | 41 (29.9) | 33 (28.2) | 8 (40.0) | 45 (30.8) | 52 (29.7) | 0.86 | 0.82 |
| Cardiovascular Death | 14 (34.1) | 8 (24.2) | 6 (75.0) | 8 (17.8) | 16 (30.8) | 0.08 | 0.14 |
| Non-cardiovascular Death | 22 (53.7) | 21 (63.6) | 1 (12.5) | 29 (64.4) | 30 (57.7) | 0.31 | 0.50 |
| Unknown Cause of Death | 5 (12.2) | 4 (12.1) | 1 (12.5) | 8 (17.8) | 6 (11.5) | 0.47 | 0.38 |
| All Cause Readmission | 57 (41.6) | 49 (41.9) | 8 (40.0) | 62 (42.5) | 80 (45.7) | 0.89 | 0.56 |
| Readmission for Myocardial Infarction | 19 (33.3) | 17 (34.7) | 2 (25.0) | 13 (21.0) | 8 (10.0) | 0.19 | 0.11 |
| Readmission for Heart Failure | 12 (21.1) | 10 (20.4) | 2 (25.0) | 15 (24.2) | 19 (23.8) | 0.84 | 0.89 |
| Death or Myocardial Infarction | 54 (39.4) | 44 (37.6) | 10 (50.0) | 52 (35.6) | 57 (32.6) | 0.59 | 0.65 |
†
P1: P-value for the comparison of type 1 MI versus type 2 MI
*
P2: P-value for the comparison of type 2 MI versus myocardial injury